Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
LYMPHOMA MYELOMA AND NON-ACUTE LEUKEMIA (OTHER 691 - 4) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 31, 2026 , from http://ppman.hank.ai/transparency/procedure/691 - 4/by-state?code_type=OTHER
“LYMPHOMA MYELOMA AND NON-ACUTE LEUKEMIA (OTHER 691 - 4) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/691 - 4/by-state?code_type=OTHER. Accessed
October 31, 2026 .
“LYMPHOMA MYELOMA AND NON-ACUTE LEUKEMIA (OTHER 691 - 4) by State,” HANK Price Transparency ,
accessed October 31, 2026 ,
http://ppman.hank.ai/transparency/procedure/691 - 4/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
691 - 4 — Lymphoma Myeloma And Non-acute Leukemia
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$152,201
National median
$9,199 – $265,060
IQR (p25 – p75)
14
hospitals filing
5
states
Walking in without insurance?
Cash / self-pay price
Cash median
$283,993
vs. negotiated
+86.6%
Hospitals reporting
8
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 691 - 4 (OTHER), with interquartile range
State Median p25 p75
IL $792,541 $619,173 $871,795
CA $189,328 $725 $257,487
OH $180,419 $145,524 $248,919
NE $31,815 $31,815 $44,171
PA $9,199 $9,199 $34,108